General Discussion and Future Perspectives | 195 REFERENCES 1. Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology working group on myocardial and pericardial diseases. Eur Heart J. 2008;29(2):270–6. 2. Towbin JA, McKenna WJ, Abrams DJ, et al. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. Heart Rhythm. 2019;16(11):e301– 72. 3. Arbelo E, Protonotarios A, Gimeno JR, et al. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J. 2023;44(37):3503–626. 4. Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/Dysplasia: Proposed modification of the task force criteria. Circulation. 2010;121(13):1533–41. 5. Lie ØH, Chivulescu M, Rootwelt‐Norberg C, et al. Left Ventricular Dysfunction in Arrhythmogenic Cardiomyopathy: Association With Exercise Exposure, Genetic Basis, and Prognosis. J Am Heart Assoc. 2021;10(8). 6. Mast TP, Teske AJ, Walmsley J, et al. Right Ventricular Imaging and Computer Simulation for Electromechanical Substrate Characterization in Arrhythmogenic Right Ventricular Cardiomyopathy. J Am Coll Cardiol. 2016;68(20):2185–97. 7. Taha K, te Rijdt WP, Verstraelen TE, et al. Early Mechanical Alterations in Phospholamban Mutation Carriers. JACC Cardiovasc Imaging. 2021;14(5):885–96. 8. Protonotarios A, Bariani R, Cappelletto C, et al. Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator. Eur Heart J. 2022;43(32):3053–67. 9. Paldino A, Dal Ferro M, Stolfo D, et al. Prognostic Prediction of Genotype vs Phenotype in Genetic Cardiomyopathies. J Am Coll Cardiol. 2022;80(21):1981–94. 10. Basso C, Corrado D, Marcus FI. Arrhythmogenic right ventricular cardiomyopathy. Lancet. 2009;(373):1289–300. 11. Van Osta N, Kirkels FP, Lyon A, et al. Personalization of Biomechanical Models for Early Detection of Disease. In: Computing in Cardiology Conference. 2018. 12. Van Osta N, Lyon A, Kirkels FP, et al. Parameter subset reduction for patient-specific modelling of arrhythmogenic cardiomyopathy-related mutation carriers in the CircAdapt model: Parameter Subset Reduction. Philosophical Transactions of the Royal Society A. 2020;378(2173):20190347. 13. van Opbergen CJM, Delmar M, van Veen TAB. Potential new mechanisms of pro-arrhythmia in arrhythmogenic cardiomyopathy: focus on calcium sensitive pathways. Netherlands Heart Journal. 2017;25(3):157–69. 14. Lyon A, Dupuis LJ, Arts T, et al. Differentiating the effects of β-adrenergic stimulation and stretch on calcium and force dynamics using a novel electromechanical cardiomyocyte model. Am J Physiol Heart Circ. 2020;319(3):H519–30. 15. Osta N van, Kirkels FP, Loon T van, et al. Uncertainty Quantification of Regional Cardiac Tissue Properties in Arrhythmogenic Cardiomyopathy Using Adaptive Multiple Importance Sampling. Front Physiol. 2021;12:738926. 9
RkJQdWJsaXNoZXIy MTk4NDMw